JOUNCE THERPEUTC CM

Jounce Therapeutics to Present at Upcoming Investor Conferences in June

11 六月 2019 08:00:30 条件 Nasdaq GlobeNewswire

Jounce Therapeutics Reports First Quarter 2019 Financial Results

08 五月 2019 06:31:01 条件 Nasdaq GlobeNewswire

Jounce Therapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019

01 五月 2019 08:00:10 条件 Nasdaq GlobeNewswire

Jounce Therapeutics Presents Preclinical Data from JTX-8064 Program at the 2019 American Association for Cancer Research (AACR) Annual Meeting

03 四月 2019 08:02:00 条件 Nasdaq GlobeNewswire

Jounce Therapeutics Reports Improved PFS and OS Associated with Vopratelimab (JTX-2011) Treatment Emergent Biomarker at the 2019 American Association for Cancer Research (AACR) Annual Meeting

02 四月 2019 13:02:00 条件 Nasdaq GlobeNewswire

Jounce Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

06 三月 2019 06:30:10 条件 Nasdaq GlobeNewswire

Jounce Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference

04 三月 2019 08:01:57 条件 Nasdaq GlobeNewswire

Jounce Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Wednesday, March 6, 2019

28 二月 2019 08:00:13 条件 Nasdaq GlobeNewswire

Jounce Therapeutics to Present Data from its JTX-2011 and JTX-8064 Programs at the 2019 American Association for Cancer Research (AACR) Annual Meeting

27 二月 2019 16:35:24 条件 Nasdaq GlobeNewswire

Jounce Therapeutics Completed Enrollment in First Cohort of Phase 1 Clinical Trial with its PD-1 Inhibitor, JTX-4014

03 一月 2019 08:00:46 条件 Nasdaq GlobeNewswire

Jounce Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

02 一月 2019 08:00:40 条件 Nasdaq GlobeNewswire

Jounce Therapeutics Reports Third Quarter 2018 Financial Results

13 十一月 2018 06:30:55 条件 Nasdaq GlobeNewswire

Jounce Therapeutics Presents Reverse Translational, Biomarker and Preclinical Data from ICOS Program at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

10 十一月 2018 12:19:32 条件 Nasdaq GlobeNewswire

Jounce Therapeutics to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 13, 2018

06 十一月 2018 08:01:17 条件 Nasdaq GlobeNewswire

Jounce Therapeutics to Present Two Posters from the JTX-2011 Program at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

02 十一月 2018 13:47:56 条件 Nasdaq GlobeNewswire

Jounce Therapeutics Founder Dr. James P. Allison Jointly Awarded 2018 Nobel Prize in Physiology or Medicine for the Discovery of Cancer Therapy by Inhibition of Negative Immune Regulation

01 十月 2018 11:39:44 条件 Nasdaq GlobeNewswire

Jounce Therapeutics to Present at the 2018 Cantor Global Healthcare Conference

26 九月 2018 08:01:01 条件 Nasdaq GlobeNewswire

Jounce Therapeutics to Present at Upcoming Investor Conferences in September

29 八月 2018 08:00:46 条件 Nasdaq GlobeNewswire

Jounce Therapeutics Reports Second Quarter 2018 Financial Results

09 八月 2018 06:30:17 条件 Nasdaq GlobeNewswire

Jounce Therapeutics to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018

02 八月 2018 08:00:58 条件 Nasdaq GlobeNewswire